The Molecular Diagnostics Department in Biomedical and Clinical Sciences Focuses Particularly on Molecular-level Disease Identification and Characterization. Employing Cutting-edge Methodologies, This Department Primarily Harnesses the Power of Nucleic Acid-based Tests and Amplification Using Primers, Specific Reagents, Various Controls, and Enzymes to Pinpoint Specific Sequences in Dna and Rna That Might Be Associated With Disease. Key Assays Such as Polymerase Chain Reaction (Pcr), Quantitative Pcr (Qpcr), and Next-generation Sequencing (Ngs) Facilitate the Rapid and Accurate Detection of Genetic Mutations, Infectious Agents, and Oncogenic Transformations. The Use of Fluorescence in Situ Hybridization (Fish) Allows for the Localization of Specific Dna Sequences on Chromosomes, Aiding in the Detection of Chromosomal Abnormalities. By Utilizing These Advanced Techniques, Molecular Diagnostics Plays a Crucial Role in the Early Detection, Prognosis, Personalized Treatment Strategies, and Monitoring Ofvarious Diseases, Ensuring a Precision-based Approach to Patient Care in the Evolving Landscape of Healthcare Sciences.